Report Detail
Global Ophthalmic Anti-infective Drug Market Growth (Status and Outlook) 2022-2028
- RnM4484344 |
- 22 August, 2022 |
- Global |
- 102 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
The global market for Ophthalmic Anti-infective Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Ophthalmic Anti-infective Drug players cover Alcon, AbbVie, Bausch Health, Santen Pharmaceutical and Lupin Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Ophthalmic Anti-infective Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Ophthalmic Anti-infective Drug market, with both quantitative and qualitative data, to help readers understand how the Ophthalmic Anti-infective Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Ophthalmic Anti-infective Drug market and forecasts the market size by Type (Eyedrops, Gels and Ointments), by Application (Hospital, Retail Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Eyedrops
Gels
Ointments
Other
Segmentation by application
Hospital
Retail Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Chapter Introduction
Chapter 1: Scope of Ophthalmic Anti-infective Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Ophthalmic Anti-infective Drug market size and CAGR, Ophthalmic Anti-infective Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Ophthalmic Anti-infective Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Ophthalmic Anti-infective Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Ophthalmic Anti-infective Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Alcon, AbbVie, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Johnson & Johnson and Thea pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Ophthalmic Anti-infective Drug Market Size 2017-2028
- 2.1.2 Ophthalmic Anti-infective Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Ophthalmic Anti-infective Drug Segment by Type
- 2.2.1 Eyedrops
- 2.2.2 Gels
- 2.2.3 Ointments
- 2.2.4 Other
- 2.3 Ophthalmic Anti-infective Drug Market Size by Type
- 2.3.1 Ophthalmic Anti-infective Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
- 2.4 Ophthalmic Anti-infective Drug Segment by Application
- 2.4.1 Hospital
- 2.4.2 Retail Pharmacy
- 2.4.3 Others
- 2.5 Ophthalmic Anti-infective Drug Market Size by Application
- 2.5.1 Ophthalmic Anti-infective Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
3 Ophthalmic Anti-infective Drug Market Size by Player
- 3.1 Ophthalmic Anti-infective Drug Market Size Market Share by Players
- 3.1.1 Global Ophthalmic Anti-infective Drug Revenue by Players (2020-2022)
- 3.1.2 Global Ophthalmic Anti-infective Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Ophthalmic Anti-infective Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Ophthalmic Anti-infective Drug by Regions
- 4.1 Ophthalmic Anti-infective Drug Market Size by Regions (2017-2022)
- 4.2 Americas Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
- 4.3 APAC Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
- 4.4 Europe Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Ophthalmic Anti-infective Drug Market Size by Country (2017-2022)
- 5.2 Americas Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
- 5.3 Americas Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Ophthalmic Anti-infective Drug Market Size by Region (2017-2022)
- 6.2 APAC Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
- 6.3 APAC Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Ophthalmic Anti-infective Drug by Country (2017-2022)
- 7.2 Europe Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
- 7.3 Europe Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Ophthalmic Anti-infective Drug by Region (2017-2022)
- 8.2 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Ophthalmic Anti-infective Drug Market Forecast
- 10.1 Global Ophthalmic Anti-infective Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Ophthalmic Anti-infective Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Ophthalmic Anti-infective Drug Forecast
- 10.1.3 APAC Ophthalmic Anti-infective Drug Forecast
- 10.1.4 Europe Ophthalmic Anti-infective Drug Forecast
- 10.1.5 Middle East & Africa Ophthalmic Anti-infective Drug Forecast
- 10.2 Americas Ophthalmic Anti-infective Drug Forecast by Country (2023-2028)
- 10.2.1 United States Ophthalmic Anti-infective Drug Market Forecast
- 10.2.2 Canada Ophthalmic Anti-infective Drug Market Forecast
- 10.2.3 Mexico Ophthalmic Anti-infective Drug Market Forecast
- 10.2.4 Brazil Ophthalmic Anti-infective Drug Market Forecast
- 10.3 APAC Ophthalmic Anti-infective Drug Forecast by Region (2023-2028)
- 10.3.1 China Ophthalmic Anti-infective Drug Market Forecast
- 10.3.2 Japan Ophthalmic Anti-infective Drug Market Forecast
- 10.3.3 Korea Ophthalmic Anti-infective Drug Market Forecast
- 10.3.4 Southeast Asia Ophthalmic Anti-infective Drug Market Forecast
- 10.3.5 India Ophthalmic Anti-infective Drug Market Forecast
- 10.3.6 Australia Ophthalmic Anti-infective Drug Market Forecast
- 10.4 Europe Ophthalmic Anti-infective Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Ophthalmic Anti-infective Drug Market Forecast
- 10.4.2 France Ophthalmic Anti-infective Drug Market Forecast
- 10.4.3 UK Ophthalmic Anti-infective Drug Market Forecast
- 10.4.4 Italy Ophthalmic Anti-infective Drug Market Forecast
- 10.4.5 Russia Ophthalmic Anti-infective Drug Market Forecast
- 10.5 Middle East & Africa Ophthalmic Anti-infective Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Ophthalmic Anti-infective Drug Market Forecast
- 10.5.2 South Africa Ophthalmic Anti-infective Drug Market Forecast
- 10.5.3 Israel Ophthalmic Anti-infective Drug Market Forecast
- 10.5.4 Turkey Ophthalmic Anti-infective Drug Market Forecast
- 10.5.5 GCC Countries Ophthalmic Anti-infective Drug Market Forecast
- 10.6 Global Ophthalmic Anti-infective Drug Forecast by Type (2023-2028)
- 10.7 Global Ophthalmic Anti-infective Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Alcon
- 11.1.1 Alcon Company Information
- 11.1.2 Alcon Ophthalmic Anti-infective Drug Product Offered
- 11.1.3 Alcon Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Alcon Main Business Overview
- 11.1.5 Alcon Latest Developments
- 11.2 AbbVie
- 11.2.1 AbbVie Company Information
- 11.2.2 AbbVie Ophthalmic Anti-infective Drug Product Offered
- 11.2.3 AbbVie Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 AbbVie Main Business Overview
- 11.2.5 AbbVie Latest Developments
- 11.3 Bausch Health
- 11.3.1 Bausch Health Company Information
- 11.3.2 Bausch Health Ophthalmic Anti-infective Drug Product Offered
- 11.3.3 Bausch Health Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Bausch Health Main Business Overview
- 11.3.5 Bausch Health Latest Developments
- 11.4 Santen Pharmaceutical
- 11.4.1 Santen Pharmaceutical Company Information
- 11.4.2 Santen Pharmaceutical Ophthalmic Anti-infective Drug Product Offered
- 11.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Santen Pharmaceutical Main Business Overview
- 11.4.5 Santen Pharmaceutical Latest Developments
- 11.5 Lupin Pharmaceuticals
- 11.5.1 Lupin Pharmaceuticals Company Information
- 11.5.2 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product Offered
- 11.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Lupin Pharmaceuticals Main Business Overview
- 11.5.5 Lupin Pharmaceuticals Latest Developments
- 11.6 Apotex
- 11.6.1 Apotex Company Information
- 11.6.2 Apotex Ophthalmic Anti-infective Drug Product Offered
- 11.6.3 Apotex Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Apotex Main Business Overview
- 11.6.5 Apotex Latest Developments
- 11.7 Akorn
- 11.7.1 Akorn Company Information
- 11.7.2 Akorn Ophthalmic Anti-infective Drug Product Offered
- 11.7.3 Akorn Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Akorn Main Business Overview
- 11.7.5 Akorn Latest Developments
- 11.8 Johnson & Johnson
- 11.8.1 Johnson & Johnson Company Information
- 11.8.2 Johnson & Johnson Ophthalmic Anti-infective Drug Product Offered
- 11.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Johnson & Johnson Main Business Overview
- 11.8.5 Johnson & Johnson Latest Developments
- 11.9 Thea pharmaceuticals
- 11.9.1 Thea pharmaceuticals Company Information
- 11.9.2 Thea pharmaceuticals Ophthalmic Anti-infective Drug Product Offered
- 11.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Thea pharmaceuticals Main Business Overview
- 11.9.5 Thea pharmaceuticals Latest Developments
- 11.10 URSAPHARM
- 11.10.1 URSAPHARM Company Information
- 11.10.2 URSAPHARM Ophthalmic Anti-infective Drug Product Offered
- 11.10.3 URSAPHARM Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 URSAPHARM Main Business Overview
- 11.10.5 URSAPHARM Latest Developments
- 11.11 SIMILASAN
- 11.11.1 SIMILASAN Company Information
- 11.11.2 SIMILASAN Ophthalmic Anti-infective Drug Product Offered
- 11.11.3 SIMILASAN Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 SIMILASAN Main Business Overview
- 11.11.5 SIMILASAN Latest Developments
- 11.12 Jianfeng Group
- 11.12.1 Jianfeng Group Company Information
- 11.12.2 Jianfeng Group Ophthalmic Anti-infective Drug Product Offered
- 11.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Jianfeng Group Main Business Overview
- 11.12.5 Jianfeng Group Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Ophthalmic Anti-infective Drug. Industry analysis & Market Report on Ophthalmic Anti-infective Drug is a syndicated market report, published as Global Ophthalmic Anti-infective Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Ophthalmic Anti-infective Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
